Sign in

Matthew Conlin

Chief Customer Officer at FluentFluent
Executive
Board

About Matthew Conlin

Matthew Conlin (age 41) is Co‑Founder and Chief Customer Officer of Fluent, Inc. (since July 2021), previously President (Mar 2018–Jun 2021) and U.S. Sales Director at Clash Media; he holds a B.S. in Marketing from St. John’s University and has served on FLNT’s board since 2018 . During 2022–2024, FLNT’s shareholder return was negative (value of a $100 investment fell 45.2% in 2022, 66.3% in 2023, 78.9% in 2024), and the company reported net losses, underscoring challenging operating performance . Revenues declined from FY2022 to FY2024 and EBITDA compressed over the same period (see Performance tables below).* Values retrieved from S&P Global.

Board service and independence: Conlin is a management director (not listed among the board’s “independent” directors) and currently holds no committee seats; the board’s independent Chair is Donald Mathis, and a Lead Independent Director structure is in place, mitigating dual‑role risks .

Past Roles

OrganizationRoleYearsStrategic impact
Fluent, Inc.President2018–2021Co-led transition to public‑company operating structure; later moved to customer leadership .
Fluent, LLCCo‑Founder2010–presentCo-founded core performance marketing platform (now wholly‑owned subsidiary) .
Clash Media (global digital ad network)Sales Director, U.S.n/dCommercial leadership in performance advertising .

External Roles

OrganizationRoleYearsNotes
Clash MediaU.S. Sales Directorn/dPrior to co‑founding Fluent .

Fixed Compensation

Metric20232024
Base Salary ($)320,214 301,378 (20% reduction effective Apr 1, 2023 carried through 2024)
Target Cash Bonus (% of salary)≥100% of salary (plan terms) ≥100% of salary; 2024 bonus formula 100% tied to company performance
Actual Cash Bonus Paid ($)0 22,526 (Q1 payout only)
Stock Awards ($, grant‑date FV)436,933 269,228
All Other Compensation ($)12,704 12,055
Total ($)769,851 605,187

Performance Compensation

Annual Cash Incentive (2024)

MetricWeightingTargetActualPayoutNotes
Revenuen/dCompany scorecardQ1 met22,526Eligible 2024 metrics tied to Revenue, Adjusted EBITDA, and strategic targets (collectively “EBITDA Goal Bonus”) .
Adjusted EBITDAn/dCompany scorecardQ1 met22,526Q1 bonus paid; no other 2024 quarterly bonuses paid .
Strategic initiativesn/dCompany scorecardQ1 met22,526n/d .
Media Margin initiatives & personal goalsn/dCompany scorecardn/d0“Media Margin” (non‑GAAP) included; see 10‑K refs in proxy .

Notes: 2024 cash bonus program was 100% company‑performance‑based for executives; Q1 only payout was made, no payouts for the remaining quarters .

Equity Awards (selected outstanding/awarded)

Grant dateInstrumentShares/UnitsVestingPerformance condition/notes
Oct 3, 2022PSUs33,889Cumulative vest 3/1/202512.5% achievement as of 12/31/2024 .
Mar 24, 2023PSUs30,556Cumulative vest 3/1/2026Assumes 12.5% expected achievement for valuation .
May 8, 2024PSUs50,000Cumulative vest 4/30/2027Assumes 12.5% expected achievement for valuation .
Various historicalRSUs (deferred delivery)113,333Vested; delivery deferredDelivery upon change of control or employment termination (91,667 + 8,333 + 13,333) .

Equity Ownership & Alignment

CategoryAmountDetail/terms
Total beneficial ownership (common)2,367,951 shares (11.27% of outstanding)Includes direct and indirect holdings; based on 20,643,660 shares outstanding at 4/24/2025 .
Direct/common and affiliated entities1,487,831 (direct) + 333,334 (RSMC Partners LLC) + 125,039 (Conlin Family Foundation Trust) + 60,175 (2017 Conlin Shakra Family Trust)Entity/trust breakdown .
Convertible Note (insider financing)361,572 shares issuable$1,000,000 Convertible Note + accrued interest; conversion price lesser of $3.01 and a floor formula ≥$1.00; subject to 19.99% cap and shareholder approval mechanics .
Pre‑Funded Warrants (Nov 29, 2024)172,771 (Conlin) + 86,385 (family trust)Price $2.3147 per warrant; exercise price $0.0005; exercisable only upon shareholder approval per Nasdaq rules .
Pre‑Funded Warrants (Mar 19, 2025)689,927 (Conlin) + 229,990 (family trust)Price $2.174 per warrant; exercise price $0.0005; shareholder approval mechanics .
Unvested PSUs (select tranches)33,889 (2022) + 30,556 (2023) + 50,000 (2024)Vesting through 2025–2027 per footnotes .
Deferred RSUs (vested, undelivered)113,333Deliverable on change of control or termination .
Pledging/HedgingNone pledged; hedging/pledging prohibitedCompany policy prohibits hedging/pledging; none pledged as of 12/31/2024 .

Related alignment considerations:

  • Participation in insider financings (Convertible Notes and Pre‑Funded Warrants) increases future potential share issuance and may contribute to supply overhang upon exercise/convertibility, subject to shareholder approvals and exchange rules .

Employment Terms

TermDetails
Current roleChief Customer Officer since July 1, 2021; previously President (Mar 2018–Jun 2021) .
Employment agreementAmended and restated effective Sept 11, 2018; terms mirror co‑founder Schulke’s .
Base salaryReduced 20% effective Apr 1, 2023 to $301,378 in 2024 .
Target bonusNo less than 100% of salary; 2023–2024 plan tied 100% to company performance (moved from 50/50 company/personal) .
Severance (non‑CIC)If terminated without cause or resigns for good reason: greater of remaining term base salary or 12 months’ base salary + prior year unpaid bonus + prorated current bonus (subject to release and compliance with restrictive covenants) .
Change‑in‑control equityUnder 2022 Plan, on termination without cause within 24 months post‑CIC: time‑based awards vest in full; performance‑based vest at target (committee discretion applies) .
ClawbackNasdaq Rule 10D‑1 compliant clawback policy effective Oct 2, 2023 (3‑year lookback for erroneous incentive comp) .
Non‑compete/Non‑solicitRestrictive covenants referenced; specific durations not disclosed .

Board Governance (Director‑Specific)

  • Board service: Director since 2018; management (non‑independent) director .
  • Committees: Not listed on Audit, Compensation or Nominating committees; those committees consist of independent directors (Kohn/Mathis/Graff/Pfenniger) .
  • Board structure: Independent Chair (Donald Mathis) appointed June 9, 2024; Lead Independent Director framework in place, enhancing oversight separation from management .
  • Attendance: In 2024, all incumbent directors attended ≥75% of aggregate board/committee meetings (individual rates not disclosed) .
  • Director compensation: Non‑employee director fee/equity program disclosed; Conlin, as an employee director, is not in the non‑employee director compensation table .

Say‑on‑Pay & Shareholder Feedback

  • Say‑on‑Pay received 98.20% support at the June 5, 2024 annual meeting; the Compensation Committee maintained program structure given strong support .

Related‑Party & Financing Transactions (insider participation)

  • Convertible Notes (Aug 19, 2024): Insiders (including Conlin) purchased notes accruing 13% interest, maturing Apr 2, 2029; conversion price is the lesser of $3.01 and a price‑floor formula, with a hard floor of $1.00 until shareholder approval; issuance above 19.99% cap and certain pricing thresholds requires shareholder approval (Nasdaq Rules 5635(b)/(c)/(d)) . Conlin’s beneficial table assumes 361,572 shares issuable on conversion of his $1,000,000 note + accrued interest at $3.01; actual convertibility remains subject to caps/approvals .
  • Pre‑Funded Warrants: November 29, 2024 (aggregate insider tranche up to 539,908 shares) and March 19, 2025 (up to 1,711,130 shares) sold to directors/officers (including Conlin/family trusts); exercise price $0.0005, with shareholder approval conditions under Nasdaq rules; per‑warrant prices $2.3147 (Nov) and $2.174 (Mar) .
  • The proxy’s related‑party section states no current related‑party transactions above the defined threshold; however, the insider financings described above are separately presented for shareholder approval and governance compliance .

Performance (Company context)

Annual fundamentals

MetricFY 2022FY 2023FY 2024
Revenues ($)361,134,000*298,399,000*254,623,000*
EBITDA ($)18,516,000*3,085,000*(7,510,000)*

Values marked with * retrieved from S&P Global.

Quarterly trend (most recent four quarters)

MetricQ4 2024Q1 2025Q2 2025Q3 2025
Revenues ($)65,407,000*55,210,000*44,706,000*47,029,000*
EBITDA ($)(289,000)*(3,434,000)*(3,714,000)*(3,825,000)*

Values marked with * retrieved from S&P Global.

Additional context: Pay‑vs‑Performance table shows negative TSR trajectories over 2022–2024 and material net losses, aligning with reduced equity grant valuations and limited cash bonuses in 2023–2024 .

Risk Indicators & Red Flags

  • Insider financing participation (Convertible Notes and Pre‑Funded Warrants) by executive/director raises future issuance/overhang and potential alignment concerns without robust approval safeguards (addressed via Proposals 4–6 and Nasdaq compliance) .
  • Section 16 reporting timeliness: the company notes Conlin failed to file two transactions on time in 2024 (Form 4) .
  • Anti‑hedging/pledging policy in place; as of 12/31/24, no pledges by directors or officers (governance positive) .
  • Say‑on‑Pay support strong (98.20%), reducing near‑term compensation policy pressure .

Board Service History, Committees, and Dual‑Role Implications

  • Service since: Director since 2018 .
  • Committees: None (all standing committees composed of independent directors) .
  • Independence: Not listed among independent directors; is an executive officer and co‑founder .
  • Dual‑role risk mitigants: Independent Chair (Mathis) and Lead Independent Director structure; separation of CEO and Chair roles .

Investment Implications

  • Alignment: Conlin’s substantial ownership (11.27%) and additional exposure via insider financings/PSUs indicate high equity linkage; hedging/pledging prohibitions support true exposure .
  • Retention: Multi‑year PSUs (2025–2027) and deferred RSUs create retention hooks; severance provides 12 months’ base (or remainder of term) plus bonus accruals—moderate protections without outsized cash parachutes; equity accelerates at target if terminated without cause post‑CIC .
  • Trading signals: On approval/convertibility of pre‑funded warrants and notes, incremental supply could pressure shares; monitor shareholder votes on Proposals 4–6 and subsequent Form 4 activity for potential sales following share issuances .
  • Pay‑for‑performance: Bonuses were tightly constrained (Q1 2024 only); PSU reliance and negative TSR backdrop suggest program sensitivity to financial performance; Say‑on‑Pay support reduces near‑term governance risk but performance execution remains key .